Optimisation of Glycaemic Control in the Setting of Antenatal Corticosteroid Administration in Pregnancies Complicated by Diabetes

Not Applicable

Completed

• Conditions: Diabetes in pregnancy; Metabolic and Endocrine - Diabetes; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy

• Registration Number: ACTRN12614001083684
• Lead Sponsor: Royal Prince Alfred Hospital Diabetes Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-10-09
• Study Completion: 2017-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 19

Inclusion Criteria

All women with diabetes in pregnancy (including gestational diabetes and pre-existing diabetes) admitted onto the antenatal or delivery ward at Royal Prince Alfred Hospital who receive emergency or elective antenatal corticosteroids for threatened pre-term delivery.

Exclusion Criteria

Women with diabetes in pregnancy who received a dose of antenatal corticosteroids at another institution prior to transfer to Royal Prince Alfred Hospital

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Optimisation of glycaemic control (maternal blood glucose targets 4.0-8.0mmol/L)[72 hours post-antenatal corticosteroid administration]

Secondary Outcome Measures

Name	Time	Method
Incidence of maternal hypoglycaemia (defined as blood glucose level < 4.0 mmol/L) as assessed by bedside glucometer[72 hours post administration of antenatal corticosteroid therapy]